The Power of Specificity: Bacilysin and Glucosamine 6-Phosphate Synthase Inhibition
In the realm of antimicrobial research, specificity is a highly prized attribute, and Bacilysin exemplifies this principle perfectly. Identified by its CAS number 1395-22-8, this dipeptide antibiotic, originally discovered as a metabolite of Bacillus subtilis, exerts its potent antibacterial effects by specifically targeting glucosamine 6-phosphate synthase. This targeted action makes it an invaluable research chemical for scientists dissecting bacterial cellular processes.
Glucosamine 6-phosphate synthase is a critical enzyme involved in the biosynthesis of UDP-N-acetylglucosamine, a precursor essential for the formation of peptidoglycan. Peptidoglycan is the rigid outer layer that gives bacteria their shape and protects them from osmotic lysis. By inhibiting this key enzyme, Bacilysin effectively disrupts cell wall integrity, leading to bacterial death. This precise mechanism of action is what makes Bacilysin a compound of significant interest for researchers aiming to develop new antibiotics or understand the fundamental processes of bacterial growth.
The ability to buy Bacilysin allows researchers to conduct detailed studies on enzyme kinetics, competitive inhibition, and the development of resistance mechanisms. Its well-defined molecular formula, C12H18N2O5, and molecular weight of 270.283 provide a solid foundation for these investigations. As a product of Bacillus subtilis, it also offers insights into microbial secondary metabolism and the evolutionary strategies employed by bacteria to survive and compete.
For those working in drug discovery, Bacilysin serves as a critical benchmark compound. Its established efficacy and specific target make it an ideal reference for screening new potential drug candidates. By understanding how Bacilysin interacts with glucosamine 6-phosphate synthase, scientists can design molecules with similar or improved inhibitory capabilities, potentially leading to the next generation of antibacterial therapies. The availability of Bacilysin CAS 1395-22-8 from reliable manufacturers ensures that this vital research tool remains accessible to the scientific community.
Perspectives & Insights
Core Pioneer 24
“For those working in drug discovery, Bacilysin serves as a critical benchmark compound.”
Silicon Explorer X
“Its established efficacy and specific target make it an ideal reference for screening new potential drug candidates.”
Quantum Catalyst AI
“By understanding how Bacilysin interacts with glucosamine 6-phosphate synthase, scientists can design molecules with similar or improved inhibitory capabilities, potentially leading to the next generation of antibacterial therapies.”